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T h e  s u c c e s s  o f  a  c o r n e a L  t r a n s p l a n t a t i o n  i s j e o p a r d i s e d  t h e  m o s t  b y
i m m u n o L o g i c  r e j e c t i o n  o f t h e  a L l o g r a f t .  T h e  a i m  o f t h j s  t h e s i s  i s  t o
u n  r a v e L  t h e  í m  m u n o L o g i c a  L  m e c h a n j s m  u n d e r L y i n g  c o r n e a L  a L L o g r a f t
re jec t ion  w i th  respec t  to  the  cont r ibu t ion  o f  macrophaqes.  In chapter  2
backgrou n  d  i  n fo rmat ion  con cern i  n  g  cornea La  LLogra f t  re jec t io  n is  p re-
s e n t e d .  I n  t h e  c o n s e c u t i v e  c h a p t e r s  e x p e r i m e n t s  a r e  d e s c r i b e d ,  t h a t
i n v e s r i g a t e  h e  e í f e c t  o Í  l o r a l  m a c r  o p h a g e  d e p l e l  i o n .  u s i n g  t I o d r o n a r e
l iposomes,  on  var ious  aspec ts  o f  exper imentaL aLLogra f t  re jec t ion  in  a
. - +  - ^ . ^ ^ - l  + . - - - ^ l  - - + - + i ^r a T  c o r n e a r  r r a n S p t a n T a l l o n  m o 0 e r .
Clodronate l iposomes can protong graft survival after corneal
transplantat ion in pre-vascularised corneas
P r e v i o u s  e x p e r i m e n t s  i n a  r a t  c o r n e a L t r a n s p L a n t a t i o n  m c r d e L  h a v e  b e e n
d e m o n s t r a t e d  t h a t  r e p e a t e d  s u b c o n j u n c t i v a  L  a d m i  n i s t r a t i o n  o f  c L o d r o -
na te  L iposomes prevents  g ra f t  re jec t ion  and reduce pos topera t ive
g r o w t h  o f  n e o v a s c u L a r i s a t i o n .  R e s u L t s  d e s c r i b e d  i n  c h a p t e r  3  r e v e a L
t h a t  e v e n  t h  o u g  h  t h  e  r e c i  p i e n t  c o r n e a  Lb e d  i s  n  e o v a s c u t a  r i s e d  a t  t i  m e
. í , .  - ' . - - 1 . - + - ! : ^ . .  ^ ^ - -  -  r l  n r e Í l  r e i c r t i n n  r : n  h o  d o r . . . . r  .  -  ^ !  t  . - - !U l  l l d l l ) p t d l l L d L l U l L ,  ( U r l l C G .  r , - ,  - , L d y e u  l U l  d l  l C d ) L
6  w e e k s  w h e n  c L o d r o n a t e  l i p o s o m e s  w e r e  i n j e c t e d  L o c a L L y ,  w h e r e a s  a L l
un t rea ted  rec ip ien ts  have re jec ted  the i r  g ra f t  w i th in  two weeks .
F u r t h e r m o r e ,  p o s t o p e r a t í v e  n o v a s c u [ a r i s a t i o n  w a s  a L s o  r e d u c e d  i n
r . o l  n e d 5  o f  p r e - v a s c u  l a  r i s e d  c  I  o d r o n a l  e I  i u o s o m e - t r e a  t e d  r e c i p i e n t s .
Inf luence of macrophage deplet ion on the expression of costimula-
tory molecules after orthotopic corneal al lotransplantat ion
C o s t i m u L a t o r y  s i g n a L s  s u c h  a s  a d h e s i o n  m o L e c u L e s  a t t r a c t i m m u n e  c e I L s
to  in f lamed areas  and fac iL j ta te  in te rac t ions  be tween ceLLs .  In chapter  4
i t  w a s  d e m o n s t r a t e d  t h a t  m a c r o p h a g e  d e p L e t i o n  d i m i n i s h e d  a d h e s i o n
m o L e c u L e  e x p r e s s i o n  ( I C A M - 1  a n d  B 2 - i n t e g r i n s )  o n  o c u L a r  t j s s u e  a  n d
i m m u n e  c e L L s ,  o t h e r w i s e  u p r e g u L a t e d  d u r i n g  c o r n e a L  g r a f t  r e j e c t i o n .
F u r t h e r  i n s i g h t i n  t h e  e f f e c t  o f  m a c r o p h a g e  d e p L e t i o n  w a s  g a i n e d  b y
charac ter isa t ion  f the  cy tok ine  pro f i le  found in  c lodronate  L iposome-
t rea ted  rec ip ien ts  a f te r t ranspLanta t ion .  The s tudy  presented  in  chapter  5
s h o w e d  t h a t  L o c a L  m a c r o p h a g e  d p L e t i o n  r e d u c e d  t h e  e x p r e s s i o n  o f
mRNA for  cy tok ines  produced by  macrophages such as  IL -1RA,  IL -10 ,
MCP-1,  and l '4 IP-2  in  the  rec ip ien t  par t  o f the  cornea as  weLL as  the
express ion  o f l l -1 .8 ,  IL -6 ,  and IFN-y  m RNA in  bo th  the  rec ip ien t  cornea
a n d  g r a f t .  I n  a d d i t j o n ,  e x p r e s s i o n  o f m R N A  f o r ï h 1  c y t o k i n e s  s u c h  a s
IL-2 ,  TNF-É and the  Th2 cy tok ine  IL -4  was found to  be  decreased in gra f ts
o f  c lodronate  L iposome- t rea ted  r c ip ien ts .  RemarkabLy,  the  macropha ge
der ived  cy tok ine  IL1 .2p40 was unaLtered  by the  cLodronate  L iposome t rea t -
ment a pa rt from a transient in crease i n th e graft th ree days after
grafting. Moreover. ctodronate [iposome treatment increased TN F-a
m RNA levets in the fi rst week after atlotransplantation.
Is prevention of corneal graft rejection via clodronate
liposomes appticabte in different rat strain combinations?
In previous experiments, described inchapter 3 and 4, a rat corneaI
transp[antation model (DA r F344) was used jn which priorto grafting
keratit is was induced usi ng heat-inactivated rabbit seru m to synch ro-
nise the rejection time. In chapter 6 ctodronate [iposomes were
adminis t rated in  a d i f ferent  rat  s t ra in combinat jon (PVG . ;  A0)  and
wj thout  pre-operat ive manipulat ion f the rec ip ient  cornea.  I t
appeared that graft rejection coutd a[so be prevented by subcon-
junct ivaI  adminis t rat ion fc [odronate [ iposomes in th is  rat  s t ra in
combinat ion.  A[ [  untreated rec ip ients underwent  graf t  re ject ion
wi th in two weeks and c lodronate [ ioosome-t reated rats d id not
reject for at least L00 days.
Macrophage depletion after orthotopic corneat atlotransptanta-
tion renders the graft immunological invisible to the recipient
Ef fector  mechanisms ediat ing in  corneaI  at lograf t  re ject ion are
DTH, CTL and ant ibodies.  In chapter  6 i t  was repor ted that  local
macrophage d plet ion downregulated CïL responses d i rected
towards donor ant igens in  both Local .  Lymph nodes as wet l  as in  the
spleen.  A[so ant ibodies speci f ic  for  donor ant igens are absent  in
ctodronate [iposome-treated recipients whereas on postoperative
day 17 these ant ibodies can be found' in  sera of  untreated rats.
Fur thermore.  induct ion of  DTH responses d i rected towards donor
ant igens i  prevented as tested in  chapter  7.  At though the absence
of  donor-speci f ic  DTH responses coutd be expta ined by the presence
of toterance v ia ACAID th is  was demonstrated not  to  be the case in
ctodronate [ iposome-t reated r c ip ients.  These xper iments hetp to
understand why ctodronate [ iposome-t reated r c ip ients bear  [ong-
term accepted corneaI  graf ts ;  namely the absence of  ef fector
mechanisms suggest  that  the immunomodulat jon provided by th is
t reatment  modat i ty  renders the at tograf t  i  mmuno[ogicat ty  i  nv is ib l "e.
Systemic effect of subconjunctivatty injected ctodronate liposomes
In chapter 6 it was shown that subconjunctivalinjections wjth clo-
dronate [ iposomes do not  downregutate the generat ion ofh igh CTL
responses d i rected towards a l toant igens in  the submandibutar  and
mesenter ic  lymph nodes af ter  in t raper i toneaI  i  n ject ion of  at toant i -





s p e c i  f r c  f o r  a  l l o a  n t i q e n s  i s  n  o t  p r  e v e n t e d  b y  t h e s e  [ o c a  I  i  n j e c t i o  r r s .
I n  a d r l i t j o n ,  e x p c r i n r e n t s  d e s c r i b e d  i n  c h a p t e r  7  s h o l v e d  t h a t  s L t b c o n -
j u r c t i v a I a d m i n i s t r a t e d  c t o d r o n a t e  l i p o s o r l e s  h a v e  n o  e f f e c t o n  t h e
a b i l i t y  t o  q e n e r a l e  a L L o a n t i g r : n  s p e c i f i c  D T H  r e s p o n s e s  n o T  t s  l l l l u n e
p r i v i L e g e  o f t h e  e y e  w i t h  r e s p e c t  t o  t h e  c a p a c i t y  t o  i n d u c e  A C A I D
t h r e a l e n e d .
The resuLts  ta l<en toc le ther  conf i rn t  a  very  Loca l i sed  e f fec t  by  cLodronate
L i p o s o m e s  i n  p r e v e n t i n q  g r a f L  r e j e c t i o n  a f t e r  c o r n e a I  t r a n s p l a n l a t i o n
a n d  s e e n r  p r o r n i s i n q  f o r  t h e  u s e  o f  c l o d r o n a t e  l i p o s o r l e s  a s  a  f u t u r e
t h e r a p y .
T h e  e f f i c i e n c y  o l  c l o d r o n a t e  I i p o s o m e s  t o  p r o l o n g  g r a f t  s u r v i v a L
af te r  o r tho top ic  cornea l  a i lo t ransp lan ta t ion  is  op t ima l  when
admin is t ra ted  in  the  a f fe ren t  phase o f  g ra f t  re jec t ion
D j f f e r e n t  a d n r  i  n  i s t r a l i o  r r  s c h e d u L e s  l o r  c I o d  r o n a t e  L i p o s o r n e  t í e a t n t e n t
l ' " r e r e  a n a L y s e d  i r  c h a p t e r  B .  I t  a p p e a r e d  t h a t  o n L y  a  s i n g l e  i n j e c t i o n  o f
c [ o d r o n a t e  L i p o s o m e s  c o u L d  a i r e a d y  p r o l o n g  q r a i t  r e l e c t i o n  a f l e r  c o r n e a L
a L l o t r a  n s p [ a  n t a t  i o n  w h e n  a d  n r i  n i s t r a t e d  i  r e c t l y  a f  t e r  g r a f t i  n  g .
D e l a y i n g  t h i s  s i n g L e . r d n r i n i s t r a t i o n  f o r  s i x  d a y s  c o m p L e t e l y  a b o L i s h e d  t h e
prevenL ive  e f fec t  on  re jec t lon  by  c lodronate  I iposor les .  T lvo  in . jec t io r rs
o f  c l o d r o n a t e  L i p o s o m e s ,  d i r e c t [ y  a f t e r  g r a f t i n q  a n d  t l v o  d a v s  l a 1 e r ,
\ / e r e  a s  e f f e c t i v e  i n  p r o L o n q i n q l  g r a f t  s u r v i v a L  a s  w e r e  f i v e  r e p e a t e d
i n j e c t i o n s  a d r n i n j s t r a t e d  d i r e c t l y  a f t e r  g r a f t i n g  a n d  2 , 4 ,  6 ,  a n d
B  d a y s  l a t e r .  S o  j n  o r d e r  t o  p r e v e n t  g r a f t  r e j c c t i o n  a f t e r  c o r n c a l  a L L o
t r a r s p l a n t a t i o n  i t  j s  m a r d a t o r y  t o  d e p l e l e  n r a c r o p l r a g o s  i n  l h e  a f f e r e n t
, ' . r  e r ' ' o - n o a l ! - r "  - _ p  i o
Ef fec t  o f  c lodronate  l iposomes on  the  immunoh is to iog ica i  pa t te rn
seen after orthotopic corneal al lotransplantat ion
- [ m m u n o h i s t o l o g i c a L  c h a r a c t e r i s a t j o n  f  c L e a r  c o r n e a l  q l r a Í t s ,  f o u n d  i n
aL[ogra f ted  rec ip ien ts  t rea ted  tw ice  w i t l r  c lodrona le  L iposonres  a f te r
cornea l  t ransp la  n ta t ion ,  dentons t ra te  ha t  no l  on  ly  i  l r f  Lux  o f  macropha ges
i s  i  n  h i  b i t e d ,  b u t  t h a t  t h e r e  i s  a  [ s o  r e d u c e d  i  n f L L r x  o f d e n d r i t i c  e l L s  an  d
T  L y m p l r o c y t e s  ( c h a p t e r  B ) .  T h e s e  r e s u L t s  o n c . e  a g a i n  s t r o n g l y  s u q g e s t  a
r o l e  f o r  r n a c r o p h a g e s  j n  t h e  a f f e r e n t  p h a s e  o f g r a f t  r e j e c t i o n .
C o n c l u d i n g  r e m a r k s
F r o n . r  t l r e  a b o r . r e  m e n L i o n e d  e x p c r i n t e n t s  i t  c a n  b e  l n r p L i e d  t h a t
n r a c r o p h a q e s  p L a y  a r o L e  i n  t h e  a f f e r e n t  p h a s e  o l c o r n e . r L  g r a f t  r e j e c
l r o r .  N a m e L y ,  l o c a l  c l o d r o n a t e  l i p o s o r l e s  s e e n t  i o  h i d e  t h e  a [ o g r a f t
f r o n r  t h e  i n d u c t i o n  o f  d e s t r L r c t i v e  e f f e c t o r  n t e c h a n i s m s  a n d  t h e  m o s t
o p t i r l a l  t r r r r e  p o i n t s  f o r  e f f e c t i v e  c L o d r o n a t e  l i p o s o r n e  t r e a t  m e n t  a r e
i n  t l r e  e a r l y  p h a s e  o f  c o r n e a l  g r a f t  r e j e c t i o n .
With  th js  jn  mjnd  severa I  hypotheses  can be  cons idered to  expLa in
why macrophage depte t ion  pro longs  gra f t  surv iva t .  Macrophages
cou[d  be  cons jdered as  a  poss ibLe source  o f  ang iogen ic  fac to rs ,
s jnce  i t  was  demonst ra ted  tha t  c todronate  [ iposomes reduce corne-
a I  neovascu la r isa t ion  a d  tha t  mRNA leve ts  o f IL -1 ,  IL -6 ,  and IL -8
are  downreguta ted  in corneas  o f t rea ted  rec ip ien ts .  I t i s  h ighLy  t i ke-
Ly  tha t  macrophages no t  on ly  induce neovascuLar isa t jon  bu t aLso
Lymp ha n  g iogenes is .  An o ther  a  l te rna t jve  func t ion  fo r  macropha ges
coutd  be  the  process ing  or  even more  presenta t ion  o fan t igens  to
T Lymphocy tes .  As  par t  o f the  jnnate  immune sys tem they  may a lso
be respons ib te  fo r  des t ruc t ion  o f t j ssues ,  a t t ime o fsurgery  induced
in f lammat ion ,  enabt ing  a t loant igens  to  be  p icked up  by  macrophages
and/or  APCs.  0 r  cou td  the  amount  o fcy tok ines  produced by
macrophages be  ind ispensabte  dur ing  the  gra f t  re jec t ion  process
so tha t  recru i tment  and s t imu la t ion  o fo ther  immune ce t ts  such as
Langerhans  ce t ls  and ï  l ymphocy tes  i hampered? 0nLy  fu tu re
exper iments  can reso tve  the  ques t ion  jn  wh jch  phase o f the  a f fe ren t
arc  o f  corneaL gra f t  re jec t ion  macrophages p tay  a  key  ro te .  So fa r ,
c lodronate  [ iposomes appear to  be  a  p romis ing  too I fo r  p revent ion
of  corneaI  q ra f t  re iec t ion .
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Chapter 9
Summary
